Retrospective cohort study reveals rapid reduction in mesorectal fat area after bariatric surgery, suggesting metabolic optimization strategies before rectal cancer resection.
Introduction Total mesorectal excision (TME) quality is critical for outcomes in mid- and low-rectal cancer. Larger mesorectal fat area (MFA) increases surgical difficulty and recurrence risk, yet interventions to reduce MFA remain unexplored. We examined temporal associations between bariatric surgery-associated weight loss and MFA. Methods We retrospectively reviewed 25 patients who underwent elective bariatric surgery at a university-affiliated center (2018-2023) with perioperative abdominal computed tomography imaging. Eligible patients had a computed tomography within 6 mo before and within 2 wk after surgery, plus a follow-up scan at 1-6, 6-12, or >12 mo. MFA was measured at the ischial spine level by subtracting rectal area from mesorectal package area. Absolute MFA change and percent excess weight loss (%EWL) were analyzed. Results Of 258 charts reviewed, 25 met inclusion criteria. The mean baseline body mass index was 46.2 ± 10.3 kg/m 2 and MFA 20.9 ± 6.4 cm 2 . At 1-6 mo, MFA decreased by 5.0 ± 1.9 cm 2 (−22.2%; P < 0.001) with %EWL 33.1% ( P < 0.001). At 6-12 mo, %EWL increased to 47.2% ( P = 0.003), while MFA declined an additional 3.8 ± 3.5 cm 2 (−19.3%; P = 0.07). Beyond 12 mo, %EWL reached 80.2% ( P < 0.001) with only modest further MFA change (−27.3% versus baseline; P < 0.001). Most MFA reduction occurred within 6 mo. Conclusions Bariatric surgery-associated weight loss was associated with significant early declines in MFA, largely within 6 mo. These findings support further study of metabolic optimization strategies before rectal cancer resection requiring TME.
No takes yet. Share an insight, caveat, or question.
Hijji et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: